Mark P Steele Selected Research

Mark P Steele Research Topics

7	Idiopathic Pulmonary Fibrosis 01/2019 - 04/2011
2	Fibrosis (Cirrhosis) 10/2015 - 04/2006
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2013 - 01/2007
2	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2011 - 01/2007
2	Bronchiolitis Obliterans Syndrome 04/2006 - 03/2003
2	Infections 04/2004 - 03/2004
2	Gastroesophageal Reflux (GERD) 08/2003 - 03/2003
1	Hypoxia (Hypoxemia) 10/2015
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2013
1	Disease Progression 01/2012
1	Cystic Fibrosis (Mucoviscidosis) 08/2007
1	Lung Injury 01/2007
1	Aspergillosis 04/2006
1	Empyema 03/2004
1	Arthritis (Polyarthritis) 03/2004
1	Osteomyelitis 03/2004
1	Lung Diseases (Lung Disease) 03/2004
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2003
1	Bronchiolitis Obliterans 03/2003

3	Proteins (Proteins, Gene)FDA Link 10/2015 - 04/2011
2	Biomarkers (Surrogate Marker)IBA 10/2014 - 01/2012
2	Mucin-5BIBA 06/2013 - 01/2013
2	Surface-Active Agents (Surfactants)IBA 01/2013 - 01/2007
1	Biological ProductsIBA 01/2019
1	Desmoplakins (Desmoplakin)IBA 01/2016
1	Protease Inhibitors (Protease Inhibitor)IBA 10/2015
1	P-2 (P 2)IBA 04/2011
1	MucinsIBA 04/2011
1	DNA (Deoxyribonucleic Acid)IBA 01/2007
1	Protein CIBA 01/2007
1	CollagenIBA 01/2007
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2007
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2007
1	Chemokine CXCL12IBA 01/2007
1	CholesterolIBA 04/2006
1	Ganciclovir (Cytovene)FDA LinkGeneric 04/2004
1	Itraconazole (Sporanox)FDA LinkGeneric 03/2004
1	posaconazole FDA Link 03/2004
1	liposomal amphotericin B FDA Link 03/2004